NL990012I2 - Geneesmiddelen die salmeterol en fluticason bevatten. - Google Patents
Geneesmiddelen die salmeterol en fluticason bevatten.Info
- Publication number
- NL990012I2 NL990012I2 NL990012C NL990012C NL990012I2 NL 990012 I2 NL990012 I2 NL 990012I2 NL 990012 C NL990012 C NL 990012C NL 990012 C NL990012 C NL 990012C NL 990012 I2 NL990012 I2 NL 990012I2
- Authority
- NL
- Netherlands
- Prior art keywords
- fluticasone
- medicines containing
- salmeterol
- containing salmeterol
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898920392A GB8920392D0 (en) | 1989-09-08 | 1989-09-08 | Medicaments |
GB898923644A GB8923644D0 (en) | 1989-10-20 | 1989-10-20 | Medicaments |
SG166294A SG166294G (en) | 1989-09-08 | 1994-11-18 | Inhalation medicaments for treating respiratory disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NL990012I1 NL990012I1 (nl) | 1999-07-01 |
NL990012I2 true NL990012I2 (nl) | 1999-09-01 |
Family
ID=27264677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL990012C NL990012I2 (nl) | 1989-09-08 | 1999-04-14 | Geneesmiddelen die salmeterol en fluticason bevatten. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0416951B1 (nl) |
JP (1) | JP3042867B2 (nl) |
AT (1) | ATE99941T1 (nl) |
BE (1) | BE1003053A3 (nl) |
CA (1) | CA2024916C (nl) |
CH (1) | CH680983C9 (nl) |
DE (2) | DE19975040I2 (nl) |
DK (1) | DK0416951T3 (nl) |
ES (1) | ES2062392T3 (nl) |
FR (1) | FR2651677B1 (nl) |
HK (1) | HK18695A (nl) |
HU (1) | HU211272A9 (nl) |
IE (1) | IE65535B1 (nl) |
IL (1) | IL95590A (nl) |
IT (1) | IT1241996B (nl) |
LU (1) | LU90392I2 (nl) |
NL (1) | NL990012I2 (nl) |
NZ (1) | NZ235221A (nl) |
PH (1) | PH27594A (nl) |
SG (1) | SG166294G (nl) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
HU0004452D0 (nl) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
ATE382386T1 (de) | 1998-11-13 | 2008-01-15 | Jagotec Ag | Multidosis-trockenpulverinhalator mit pulverreservoir |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
IT1317904B1 (it) | 1999-09-11 | 2003-07-15 | Glaxo Group Ltd | Formulazione farmaceutica di propionato di fluticasone. |
US20030032632A1 (en) * | 1999-12-24 | 2003-02-13 | Crispps Leslie Alan | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
AU2001275760B2 (en) * | 2000-08-05 | 2005-03-17 | Glaxo Group Limited | 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
US7144908B2 (en) | 2001-03-08 | 2006-12-05 | Glaxo Group Limited | Agonists of beta-adrenoceptors |
DE60224172T2 (de) | 2001-03-22 | 2008-12-04 | Glaxo Group Ltd., Greenford | Formanilid-derivative als beta2-adrenorezeptor-agonisten |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
AR033290A1 (es) | 2001-04-30 | 2003-12-10 | Glaxo Group Ltd | Derivados antiinflamatorios de androstano |
BRPI0212455B8 (pt) | 2001-09-14 | 2021-05-25 | Glaxo Group Ltd | composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
EP1757281A3 (en) * | 2002-02-04 | 2009-07-15 | Glaxo Group Limited | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
ES2305438T5 (es) † | 2002-02-04 | 2012-06-05 | Glaxo Group Limited | Formulación para inhalación que comprende un glucocorticoide y un agonista del ?2-adreno-receptor. |
WO2003074469A1 (de) * | 2002-03-04 | 2003-09-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel |
GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
DK1572217T3 (da) | 2002-12-12 | 2008-12-15 | Nycomed Gmbh | Kombinationsmedikament af R,R-formoterol og ciclesonid |
GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
US20070071689A1 (en) | 2003-08-06 | 2007-03-29 | Galephar M/F | Advantageous combination for inhalation of nacystelyn and bronchodilators |
EP1732526A2 (en) * | 2004-03-12 | 2006-12-20 | Cipla Ltd. | Salmeterol inhalation formulations |
UA93031C2 (uk) | 2004-07-16 | 2011-01-10 | Алміралл, С.А. | Інгалятор для порошкових медикаментів, фармацевтичний порошковий картридж для використання з інгалятором та спосіб використання інгалятора |
WO2008077623A1 (en) | 2006-12-22 | 2008-07-03 | Laboratorios Almirall, S.A. | Inhalation device for drugs in powder form |
CN101744792B (zh) * | 2008-12-17 | 2013-04-17 | 张凯 | 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺 |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
BRPI1011229B8 (pt) | 2009-05-29 | 2021-05-25 | Pearl Therapeutics Inc | co-suspensão dispensável a partir de um inalador de dose medida compreendendo propelente, partículas de agente ativo e partículas em suspensão |
BR112015022784B1 (pt) | 2013-03-15 | 2023-02-14 | Pearl Therapeutics, Inc | Método de condicionamento de material cristalino micronizado e sistemas de condicionamento |
JP2016519123A (ja) * | 2013-04-29 | 2016-06-30 | サノフィ・ソシエテ・アノニム | 吸入可能な医薬組成物およびそれらを収容した吸入器デバイス |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2107715B (en) * | 1981-10-19 | 1985-11-13 | Glaxo Group Ltd | Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it |
ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
FR2588474B1 (fr) * | 1985-10-16 | 1987-11-27 | Cird | Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste |
-
1990
- 1990-09-05 IL IL9559090A patent/IL95590A/en not_active IP Right Cessation
- 1990-09-07 DE DE1990605951 patent/DE19975040I2/de active Active
- 1990-09-07 EP EP90309846A patent/EP0416951B1/en not_active Expired - Lifetime
- 1990-09-07 AT AT90309846T patent/ATE99941T1/de active
- 1990-09-07 CA CA002024916A patent/CA2024916C/en not_active Expired - Lifetime
- 1990-09-07 ES ES90309846T patent/ES2062392T3/es not_active Expired - Lifetime
- 1990-09-07 DK DK90309846.5T patent/DK0416951T3/da active
- 1990-09-07 JP JP2235997A patent/JP3042867B2/ja not_active Expired - Lifetime
- 1990-09-07 IE IE325690A patent/IE65535B1/en not_active IP Right Cessation
- 1990-09-07 FR FR909011142A patent/FR2651677B1/fr not_active Expired - Lifetime
- 1990-09-07 DE DE69005951T patent/DE69005951T2/de not_active Expired - Lifetime
- 1990-09-07 NZ NZ235221A patent/NZ235221A/en unknown
- 1990-09-07 BE BE9000862A patent/BE1003053A3/fr not_active IP Right Cessation
- 1990-09-07 CH CH2906/90A patent/CH680983C9/de not_active IP Right Cessation
- 1990-09-07 PH PH41153A patent/PH27594A/en unknown
- 1990-09-07 IT IT48260A patent/IT1241996B/it active Protection Beyond IP Right Term
-
1994
- 1994-11-18 SG SG166294A patent/SG166294G/en unknown
-
1995
- 1995-02-09 HK HK18695A patent/HK18695A/xx not_active IP Right Cessation
- 1995-06-02 HU HU95P/P00150P patent/HU211272A9/hu unknown
-
1999
- 1999-04-14 NL NL990012C patent/NL990012I2/nl unknown
- 1999-04-26 LU LU90392C patent/LU90392I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2062392T3 (es) | 1994-12-16 |
IT9048260A1 (it) | 1992-03-07 |
IT1241996B (it) | 1994-02-02 |
PH27594A (en) | 1993-08-31 |
CA2024916C (en) | 2002-07-09 |
DE19975040I2 (de) | 2006-07-13 |
EP0416951A1 (en) | 1991-03-13 |
CH680983C1 (nl) | 2008-06-25 |
EP0416951B1 (en) | 1994-01-12 |
IE903256A1 (en) | 1991-03-13 |
IL95590A (en) | 1996-06-18 |
SG166294G (en) | 1995-06-16 |
JP3042867B2 (ja) | 2000-05-22 |
NZ235221A (en) | 1992-11-25 |
IT9048260A0 (it) | 1990-09-07 |
CH680983C9 (nl) | 2008-08-15 |
DE69005951D1 (de) | 1994-02-24 |
HK18695A (en) | 1995-02-17 |
FR2651677A1 (fr) | 1991-03-15 |
DK0416951T3 (da) | 1994-02-14 |
DE69005951T2 (de) | 1994-05-26 |
LU90392I2 (fr) | 1999-06-28 |
CA2024916A1 (en) | 1991-03-09 |
CH680983A5 (nl) | 1992-12-31 |
JPH03167120A (ja) | 1991-07-19 |
NL990012I1 (nl) | 1999-07-01 |
IE65535B1 (en) | 1995-11-01 |
IL95590A0 (en) | 1991-09-16 |
FR2651677B1 (fr) | 1993-08-06 |
ATE99941T1 (de) | 1994-01-15 |
BE1003053A3 (fr) | 1991-11-05 |
HU211272A9 (en) | 1995-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL990012I1 (nl) | Geneesmiddelen die salmeterol en fluticason bevatten. | |
DE69002718D1 (de) | Medikamente. | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
CA2123909A1 (en) | New combination of formoterol and budesonide | |
HU9202808D0 (en) | Improvement of down-regulqtion of autoimmunic diseases by means of oral dosing of autoantigenes | |
DE69200711T2 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
MY111155A (en) | Medicaments | |
JPS6438027A (en) | Remedy for cancer | |
RU93003454A (ru) | Лекарственный препарат |